SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-24-000044
Filing Date
2024-10-31
Accepted
2024-10-30 18:43:20
Documents
83
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20240930.htm   iXBRL 10-Q 2337917
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_20240930x10xq.htm EX-31 19902
3 SECTION 1350 CERTIFICATIONS amgn-ex32_20240930x10xq.htm EX-32 9565
  Complete submission text file 0000318154-24-000044.txt   10557832

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20240930.xsd EX-101.SCH 57781
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20240930_cal.xml EX-101.CAL 70573
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20240930_def.xml EX-101.DEF 331642
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20240930_lab.xml EX-101.LAB 686707
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20240930_pre.xml EX-101.PRE 512565
85 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20240930_htm.xml XML 2038951
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 241411854
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)